Long‐term efficacy and safety during open‐label erenumab treatment in Japanese patients with episodic migraine

OBJECTIVE: To assess long‐term (up to 2 years) efficacy, tolerability, and safety of erenumab for the prevention of episodic migraine (EM) in Japanese patients. BACKGROUND: Previously published results from the double‐blind treatment phase (DBTP) of a phase 2 clinical study have demonstrated the eff...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Headache
Main Authors: Sakai, Fumihiko, Takeshima, Takao, Tatsuoka, Yoshihisa, Hirata, Koichi, Cheng, Sunfa, Numachi, Yotaro, Peng, Cheng, Xue, Fei, Mikol, Daniel D.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2021
Fag:
Research Submissions
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8251924/
https://ncbi.nlm.nih.gov/pubmed/33764538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.14096
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker